30.07.2015 Views

valeant pharmaceuticals international, inc. form 6-k

valeant pharmaceuticals international, inc. form 6-k

valeant pharmaceuticals international, inc. form 6-k

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BIOVAIL CORPORATION INTERNATIONALCONSOLIDATED BALANCE SHEETS(All dollar amounts are expressed in thousands of U.S. dollars)DECEMBER 31, DECEMBER 31,1995 1994------------ ------------ASSETSCURRENTCash and short-term deposits $24,323 $ 2,819Trade accounts receivable 6,379 5,346Inventories 3,868 480Deposits and prepaid expenses 176 57------- -------34,746 8,702FIXED ASSETS, net 19,910 14,182GOODWILL, net 3,594 2,746PRODUCT RIGHTS, net 2,617 -------- -------$60,867 $25,630======= =======CURRENTLIABILITIESAccounts payable $ 5,628 $ 2,864Accrued liabilities 3,043 1,794Income taxes payable 968 736Deferred revenue 22,167 1,239Amount due on acquisition - 955Current portion of long-term debt 2,244 567------- -------34,050 8,155------- -------DEFERRED REVENUE 4,274 -------- -------LONG-TERM DEBTNon-interest bearing and forgivableinterest government loans 2,019 4,717Other 5,932 5,065------- -------7,951 9,782------- -------46,275 17,937------- -------SHAREHOLDERS' EQUITYShare capital 14,489 13,415Deficit (572) (6,442)Cumulative translation adjustment 675 720------- -------14,592 7,693------- -------$60,867 $25,630======= =======

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!